{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:11Z","timestamp":1792784831133,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Finnish Foundation of Cardiovascular Research"},{"DOI":"10.13039\/501100006432","name":"University of Oulu Graduate School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006432","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Alzheimer's disease research society"},{"name":"Finnish Alzheimer's disease foundation"},{"name":"The Finnish Brain Foundation","id":[{"id":"https:\/\/ror.org\/01qe64w73","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kyllikki and Uolevi Lehikoinen Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.atherosclerosis.2017.12.010","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T17:04:09Z","timestamp":1512752649000},"page":"294-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5900-9793","authenticated-orcid":false,"given":"Jari","family":"Kankaanp\u00e4\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritta","family":"S\u00e4mpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto","family":"Bloigu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Akhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Antero","family":"Kes\u00e4niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Remes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavi","family":"Ukkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohvi","family":"H\u00f6rkk\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.07.020","article-title":"Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians","volume":"54","author":"Cooney","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/mpat.1996.0114","article-title":"Detection of the phosphorylcholine epitope in streptococci, Haemophilus and pathogenic Neisseriae by immunoblotting","volume":"22","author":"Kolberg","year":"1997","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1749-6632.1971.tb13543.x","article-title":"Antigen-binding myeloma proteins in mice","volume":"190","author":"Potter","year":"1971","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molimm.2009.09.035","article-title":"Immunomodulation by phosphocholine\u2014biosynthesis, structures and immunological implications of parasitic PC-epitopes","volume":"47","author":"Grabitzki","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.82.6.445","article-title":"Prevention of pneumococcal pneumonia by immunization with spesific capsular polysaccharides","volume":"82","author":"MacLeod","year":"1945","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib6","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1074\/jbc.M108860200","article-title":"Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids: importance of schiff base formation and aldol condensation","volume":"277","author":"Friedman","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2009.08.013","article-title":"Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease","volume":"134","author":"Frosteg\u00e5rd","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1172\/JCI118853","article-title":"Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma","volume":"98","author":"Palinski","year":"1996","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib9","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000092891.55157.A7","article-title":"Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis","volume":"108","author":"Karvonen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib10","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","article-title":"Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib11","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.113.301145","article-title":"B\u00a0cells and humoral immunity in atherosclerosis","volume":"114","author":"Tsiantoulas","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2796.1999.00429.x","article-title":"Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects","volume":"245","author":"Rantala","year":"1999","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib13","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/oby.2010.236","article-title":"Body fat measured by a near-infrared interactance device as a predictor of cardiovascular events: the FINRISK'92 cohort","volume":"19","author":"Pajunen","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib14","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1210\/jc.2009-1858","article-title":"High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism","volume":"95","author":"S\u00e4mpi","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib15","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham heart study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0021-9150(88)90204-3","article-title":"Association of serum IgA and C4 with severe atherosclerosis","volume":"74","author":"Muscari","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0021-9150(03)00229-6","article-title":"Antibodies to human heat shock protein 60, hypertension and dyslipidemia. A study of joint effects on coronary risk","volume":"169","author":"Kervinen","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.158.13.1434","article-title":"Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M","volume":"158","author":"Kovanen","year":"1998","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib22","doi-asserted-by":"crossref","first-page":"e107440","DOI":"10.1371\/journal.pone.0107440","article-title":"Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-Protein adducts predict coronary artery disease","volume":"9","author":"Anderson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.rinim.2012.01.001","article-title":"IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL","volume":"2","author":"Fiskesund","year":"2012","journal-title":"Results Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib24","doi-asserted-by":"crossref","unstructured":"Macpherson AJ, McCoy KD, Johansen F, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol. 0000;1:11\u201322.","DOI":"10.1038\/mi.2007.6"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib25","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/clinchem\/42.7.1064","article-title":"High serum IgA concentrations in patients with diabetes mellitus: agewise distribution and relation to chronic complications","volume":"42","author":"Rodriguez-Segade","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","article-title":"Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities","volume":"151","author":"Gonzalez-Quintela","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/76261","article-title":"FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity","volume":"6","author":"van Egmond","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib30","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1128\/IAI.68.9.5416-5419.2000","article-title":"Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor","volume":"68","author":"Schenkein","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib31","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","article-title":"Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition","volume":"96","author":"Chang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib32","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.4049\/jimmunol.1303035","article-title":"Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult","volume":"192","author":"Fiskesund","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10875-012-9792-y","article-title":"Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects","volume":"33","author":"Sch\u00fctz","year":"2012","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000247","article-title":"Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis","volume":"2","author":"Ren","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib36","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/520272","article-title":"Pneumococcal vaccination in the United States and 20 other developed countries, 1981\u20131996","volume":"26","author":"Fedson","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.atherosclerosis.2017.12.010_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/EDE.0000000000000018","article-title":"Net reclassification indices for evaluating risk prediction instruments: a critical review","volume":"25","author":"Kerr","year":"2014","journal-title":"Epidemiology"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017314296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017314296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T17:59:09Z","timestamp":1617472749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017314296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":37,"alternative-id":["S0021915017314296"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.12.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}